| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/06/2013 | CN101010101B Composition comprising protein material and non-oxidizable fatty acid entities |
| 03/05/2013 | USRE44048 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder |
| 03/05/2013 | US8389747 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly; preferred compound is picropodophyllin |
| 03/05/2013 | US8389721 Solubilized topoisomerase poisons |
| 03/05/2013 | US8389546 Compounds for modulating TRPV3 function |
| 03/05/2013 | US8388977 Diagnosis of macrophage mediated disease |
| 03/05/2013 | CA2579119C Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/28/2013 | WO2013027835A1 Method for producing optically active naphthalene compound |
| 02/28/2013 | WO2013027356A1 Antibody and antibody-containing composition |
| 02/28/2013 | WO2013026755A1 Methods and compounds for reducing allergic reactions to fragranced products and perfumes |
| 02/28/2013 | WO2013026453A1 Treatment of inflammatory disorders with anthracyclines |
| 02/28/2013 | WO2012172057A3 Use of a compound comprising at least a nucleophile function for capturing carbonyl compound resulting from the reaction between one or more compounds constituting sebum and ozone |
| 02/28/2013 | WO2012166006A9 Protein-polypeptide complex with a specific effect on skin tissue, method for producing said complex and pharmaceutical composition on the basis thereof |
| 02/28/2013 | WO2012125772A3 Oral formulations for promoting cellular purification |
| 02/28/2013 | US20130053449 Method for inhibiting histone gene transcription and expression |
| 02/28/2013 | US20130053444 Dp2 antagonist and uses thereof |
| 02/28/2013 | US20130053438 Pharmaceutical compositions comprising lignans and their derivatives for the medical management of angiogenesis and hypovascularity |
| 02/28/2013 | US20130053422 Antimicrobial Compositions |
| 02/28/2013 | US20130053419 Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors |
| 02/28/2013 | US20130053395 Pyrazolopyridine kinase inhibitors |
| 02/28/2013 | US20130053394 Pyrazolopyrimidine kinase inhibitors |
| 02/28/2013 | US20130053388 Pyrazolopyrazine kinase inhibitors |
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053379 4-aryl-2-anilino-pyrimidines |
| 02/28/2013 | US20130053375 Amino-quinolines as kinase inhibitors |
| 02/28/2013 | US20130053371 Inhibitors of pi3 kinase |
| 02/28/2013 | US20130053370 THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES |
| 02/28/2013 | US20130053358 Transdermally absorbable donepezil-containing preparation |
| 02/28/2013 | US20130053357 Skin irritation suppressant and transdermal preparation |
| 02/28/2013 | US20130053356 2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3 |
| 02/28/2013 | US20130053353 Compositions, gels and foams with rheology modulators and uses |
| 02/28/2013 | US20130053345 Bicyclic heteroarly analogues as gpr119 modulators |
| 02/28/2013 | US20130053344 Synthesis of pyrrolidine compounds |
| 02/28/2013 | US20130053327 Polypeptide expressed in the stratum corneum and use thereof |
| 02/28/2013 | US20130053303 Compounds for enzyme inhibition |
| 02/28/2013 | US20130052289 Medicine containing extracts of Ficus microcarpa for healing wounds of a diabetic patient |
| 02/28/2013 | US20130052288 Collagen and Elastin Stimulating Compositions and Uses Thereof |
| 02/28/2013 | US20130052275 Warming Inch Loss Delivery System |
| 02/28/2013 | US20130052266 TABLETS CONTAINING A 1-(beta-D-GLUCOPYRANOSYL)-3-(PHENYLTHIENYLMETHYL)BENZENE COMPOUND |
| 02/28/2013 | US20130052257 Antimicrobial hydrogel wound dressing |
| 02/28/2013 | US20130052245 Cosmetic and dermatological formulations of mntf peptides |
| 02/28/2013 | US20130052213 Novel immunomodulatory peptide |
| 02/28/2013 | US20130052206 Prognostic Marker For Cryoglobulinemic Vasculitis And B Cell Malignancies In HCV Infected Patients |
| 02/28/2013 | US20130052195 Compositions Comprising TNF-alpha and IL-6 Antagonists and Methods of Use Thereof |
| 02/28/2013 | US20130052191 Anti-alpha2 integrin antibodies and their uses |
| 02/28/2013 | US20130052190 CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions |
| 02/28/2013 | US20130052184 Gelatinase inhibitors and prodrugs |
| 02/28/2013 | US20130052183 Methods for the treatment of morgellons disease |
| 02/28/2013 | US20130052174 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof |
| 02/28/2013 | US20130052170 Grafting material for genetic and cell therapy |
| 02/28/2013 | US20130052168 Methods and compositions for tissue regeneration |
| 02/28/2013 | US20130052162 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 02/28/2013 | US20130052155 Compositions and Methods for Treating a Disorder or Defect in Soft Tissue |
| 02/28/2013 | US20130052152 Protective wound dressing device for oral and pharyngeal space |
| 02/28/2013 | US20130052149 Process for treating and/or forming a non-newtonian fluid using microchannel process technology |
| 02/27/2013 | EP2561883A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561882A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561881A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2561869A1 Skin collagen production promoter |
| 02/27/2013 | EP2560679A1 Eczema treatment |
| 02/27/2013 | EP2560665A1 Cosmetic or dermatological preparations comprising combinations of magnolia bark extract and alkyl sulphates |
| 02/27/2013 | EP2560632A1 Compounds provided with antioxidant activity against free radicals, and pharmaceutical and cosmetic compositions containing them |
| 02/27/2013 | CN102946895A The use of des-aspartate-angiotensin i in inflammation-related pathologies and diseases |
| 02/27/2013 | CN102946894A Method for preparing broussonetia kazinoki extract |
| 02/27/2013 | CN102943017A Skin itch-relieving belvedere fruit health-care wine |
| 02/27/2013 | CN102942572A Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof |
| 02/27/2013 | CN102942522A Heterocyclic inhibitors of mek and methods of use thereof |
| 02/27/2013 | CN102940881A Ointment for treating skin scalds |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102940872A Traditional Chinese medicine composition for treating chilblain |
| 02/27/2013 | CN102940870A Chinese medicinal composition for treating burns and scalds |
| 02/27/2013 | CN102940854A Traditional Chinese medicine composition for facilitating wound healing after surgical operations, preparation process and application |
| 02/27/2013 | CN102940807A Freckle-removing liquid medicine and preparation method thereof |
| 02/27/2013 | CN102940804A Drug for performing disinfection, stopping bleeding and healing sore and preparation method |
| 02/27/2013 | CN102940799A Traditional Chinese medicine composition for treating leucoderma and preparation method thereof |
| 02/27/2013 | CN102940794A Traditional Chinese medicine for treating eczema and preparation method thereof |
| 02/27/2013 | CN102940781A Anti-aging and dredging Chinese medicinal composition |
| 02/27/2013 | CN102940778A External-application traditional Chinese medicine for treating decubitus |
| 02/27/2013 | CN102940759A Chinese medicinal tincture for treating porcine eczema |
| 02/27/2013 | CN102940757A Medicine composition for treating diabetic foot |
| 02/27/2013 | CN102940756A Traditional Chinese medicine for treating alopecia |
| 02/27/2013 | CN102940752A Traditional Chinese medicine composition for treating trauma |
| 02/27/2013 | CN102940728A Chinese medicine pill for curing leukotrichia |
| 02/27/2013 | CN102940727A Traditional Chinese medicine for treating alopecia areata |
| 02/27/2013 | CN102940715A Pseudo-ginseng ointment and preparation method thereof |
| 02/27/2013 | CN102940714A Traditional Chinese medicine composition for treating burn and preparation method |
| 02/27/2013 | CN102940698A Medicine for treating dermatophytosis |
| 02/27/2013 | CN102940693A Medicine composition for treating diabetic foot |
| 02/27/2013 | CN102940685A Lanceleaf anisetree extract and external transdermal absorption agent containing lanceleaf anisetree extract |
| 02/27/2013 | CN102940684A Traditional Chinese medicine composition containing illicium henryi and preparation method thereof |
| 02/27/2013 | CN102940678A Traditional Chinese medicine for treating rhagadia |
| 02/27/2013 | CN102940677A Medicine composition for treating diabetic foot |
| 02/27/2013 | CN102940665A Traditional Chinese medicine for treatment of early elephantiasis |
| 02/27/2013 | CN102940652A Eubacterium biforme preparation and use thereof |
| 02/27/2013 | CN102940648A Bee propolis soft capsule and manufacturing process thereof |
| 02/27/2013 | CN102940641A Formula of medicament for treating beriberi |
| 02/27/2013 | CN102940632A Application of FK506-A compound in preparation of immunosuppressant |
| 02/27/2013 | CN102940631A Application of Blebbistatin in promoting stem cell survival and keeping stem cell dry |
| 02/27/2013 | CN102940602A Essence powder for body care |